Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands |
Total |
Common Stock [Member] |
Treasury Stock, Common [Member] |
Additional Paid-in Capital [Member] |
Accumulated Deficit [Member] |
Other Comprehensive Loss [Member] |
Beginning balance, value at Dec. 31, 2023 |
$ (11,457)
|
$ 0
|
$ (502)
|
$ 292,467
|
$ (303,004)
|
$ (418)
|
Beginning balance, shares at Dec. 31, 2023 |
|
3,861,578
|
|
|
|
|
Beginning balance, treasury stock, shares at Dec. 31, 2023 |
|
|
(10,130)
|
|
|
|
Ending balance, value at Mar. 31, 2024 |
14,625
|
$ 1
|
$ (502)
|
320,840
|
(305,296)
|
(418)
|
Ending balance, shares at Mar. 31, 2024 |
|
8,282,221
|
|
|
|
|
Ending balance, treasury stock, shares at Mar. 31, 2024 |
|
|
(10,130)
|
|
|
|
Beginning balance, value at Dec. 31, 2023 |
(11,457)
|
$ 0
|
$ (502)
|
292,467
|
(303,004)
|
(418)
|
Beginning balance, shares at Dec. 31, 2023 |
|
3,861,578
|
|
|
|
|
Beginning balance, treasury stock, shares at Dec. 31, 2023 |
|
|
(10,130)
|
|
|
|
Release of restricted stock |
|
|
|
|
|
|
Release of restricted stock, shares |
|
99,117
|
|
|
|
|
Issuance of common stock in lieu of cash bonus and consulting fees |
35
|
|
|
35
|
|
|
Issuance of common stock in lieu of cash bonus and consulting fees, shares |
|
11,453
|
|
|
|
|
Common stock issued upon conversion of 2022 Promissory Note |
4,505
|
|
|
4,505
|
|
|
Common stock issued upon conversion of 2022 Promissory Note, shares |
|
336,550
|
|
|
|
|
Sales of common stock, net of issuance costs |
24,640
|
$ 1
|
|
24,639
|
|
|
Sales of common stock, net of issuance costs, shares |
|
4,170,051
|
|
|
|
|
Fractional share issuances as a result of reverse stock split |
|
|
|
|
|
|
Fractional share issuances as a result of reverse stock split, shares |
|
141,631
|
|
|
|
|
Stock-based compensation expense |
1,290
|
|
|
1,290
|
|
|
Net loss |
(4,923)
|
|
|
|
(4,923)
|
|
Ending balance, value at Jun. 30, 2024 |
14,090
|
$ 1
|
$ (502)
|
322,936
|
(307,927)
|
(418)
|
Ending balance, shares at Jun. 30, 2024 |
|
8,620,380
|
|
|
|
|
Ending balance, treasury stock, shares at Jun. 30, 2024 |
|
|
(10,130)
|
|
|
|
Beginning balance, value at Mar. 31, 2024 |
14,625
|
$ 1
|
$ (502)
|
320,840
|
(305,296)
|
(418)
|
Beginning balance, shares at Mar. 31, 2024 |
|
8,282,221
|
|
|
|
|
Beginning balance, treasury stock, shares at Mar. 31, 2024 |
|
|
(10,130)
|
|
|
|
Release of restricted stock |
|
|
|
|
|
|
Release of restricted stock, shares |
|
83,117
|
|
|
|
|
Sales of common stock, net of issuance costs |
1,436
|
$ 0
|
|
1,436
|
|
|
Sales of common stock, net of issuance costs, shares |
|
255,042
|
|
|
|
|
Stock-based compensation expense |
660
|
|
|
660
|
|
|
Net loss |
(2,631)
|
|
|
|
(2,631)
|
|
Ending balance, value at Jun. 30, 2024 |
14,090
|
$ 1
|
$ (502)
|
322,936
|
(307,927)
|
$ (418)
|
Ending balance, shares at Jun. 30, 2024 |
|
8,620,380
|
|
|
|
|
Ending balance, treasury stock, shares at Jun. 30, 2024 |
|
|
(10,130)
|
|
|
|
Beginning balance, value at Dec. 31, 2024 |
$ 107,183
|
$ 2
|
$ (502)
|
421,003
|
(313,320)
|
|
Beginning balance, shares at Dec. 31, 2024 |
20,156,535
|
20,166,665
|
|
|
|
|
Beginning balance, treasury stock, shares at Dec. 31, 2024 |
|
|
(10,130)
|
|
|
|
Release of restricted stock |
|
|
|
|
|
|
Release of restricted stock, shares |
|
2,168
|
|
|
|
|
Common stock issued upon conversion of 2022 Promissory Note |
0
|
|
|
|
|
|
Sales of common stock, net of issuance costs |
80
|
|
|
80
|
|
|
Sales of common stock, net of issuance costs, shares |
|
14,210
|
|
|
|
|
Stock-based compensation expense |
204
|
|
|
204
|
|
|
Net loss |
(6,867)
|
|
|
|
(6,867)
|
|
Ending balance, value at Jun. 30, 2025 |
$ 100,600
|
$ 2
|
$ (502)
|
421,287
|
(320,187)
|
|
Ending balance, shares at Jun. 30, 2025 |
20,172,913
|
20,183,043
|
|
|
|
|
Ending balance, treasury stock, shares at Jun. 30, 2025 |
|
|
(10,130)
|
|
|
|
Beginning balance, value at Mar. 31, 2025 |
$ 103,626
|
$ 2
|
$ (502)
|
421,169
|
(317,043)
|
|
Beginning balance, shares at Mar. 31, 2025 |
|
20,180,875
|
|
|
|
|
Beginning balance, treasury stock, shares at Mar. 31, 2025 |
|
|
(10,130)
|
|
|
|
Release of restricted stock |
|
|
|
|
|
|
Release of restricted stock, shares |
|
2,168
|
|
|
|
|
Stock-based compensation expense |
118
|
|
|
118
|
|
|
Net loss |
(3,144)
|
|
|
|
(3,144)
|
|
Ending balance, value at Jun. 30, 2025 |
$ 100,600
|
$ 2
|
$ (502)
|
$ 421,287
|
$ (320,187)
|
|
Ending balance, shares at Jun. 30, 2025 |
20,172,913
|
20,183,043
|
|
|
|
|
Ending balance, treasury stock, shares at Jun. 30, 2025 |
|
|
(10,130)
|
|
|
|